More Life Company signs letter of intent with US compounding pharmacy
The non-binding agreement would give the company a route into the US compounded-drug supply chain.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 6 13:41 ETSource: Yahoo Finance
The wire
- 01The More Life Company announced a letter of intent with a US compounding pharmacy.
- 02Compounding partnerships are the main channel through which many peptide products reach US patients, so ownership and supply arrangements matter to prescribers.
- 03A letter of intent is non-binding; the pharmacy's identity, 503A or 503B status, products involved and deal terms are not stated.
From the source
Read at finance.yahoo.comThe More Life Company Enters LOI With a US Compounding Pharmacy
